CONMED Corp. Stock
CONMED Corp. Stock
The CONMED Corp. price is unchanged compared to yesterday.
Currently there is a rather positive sentiment for CONMED Corp. with 3 Buy predictions and 0 Sell predictions.
With a target price of 53 € there is a positive potential of 40.96% for CONMED Corp. compared to the current price of 37.6 €.
Pros and Cons of CONMED Corp. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CONMED Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CONMED Corp. | 0.000% | 7.429% | 6.818% | -37.333% | 7.429% | -58.907% | -61.827% |
| Neogen Corp. | 2.670% | 6.630% | 20.625% | 0.521% | 56.911% | - | - |
| Merit Medical Systems | 0.000% | 1.471% | 0.000% | -30.653% | -6.757% | 7.813% | 41.975% |
| Bio-Rad Labs Inc. A | -1.520% | 6.948% | -13.521% | -15.328% | -10.469% | -48.632% | -56.434% |
Comments
CONMED (NYSE:CNMD) had its price target lowered by analysts at Piper Sandler from $68.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Corporation (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $80.00 to $68.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Needham & Company LLC from $91.00 to $61.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CNMD provided by MarketBeat